Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.

Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W.

Cochrane Database Syst Rev. 2018 Feb 28;2:CD010292. doi: 10.1002/14651858.CD010292.pub2. Review.

2.

Fibromyalgia: Treating Pain in the Juvenile Patient.

Gmuca S, Sherry DD.

Paediatr Drugs. 2017 Aug;19(4):325-338. doi: 10.1007/s40272-017-0233-5. Review.

PMID:
28536810
3.

Neurobiology of fibromyalgia and chronic widespread pain.

Sluka KA, Clauw DJ.

Neuroscience. 2016 Dec 3;338:114-129. doi: 10.1016/j.neuroscience.2016.06.006. Epub 2016 Jun 9. Review.

4.

Characterizing "fibrofog": Subjective appraisal, objective performance, and task-related brain activity during a working memory task.

Walitt B, Čeko M, Khatiwada M, Gracely JL, Rayhan R, VanMeter JW, Gracely RH.

Neuroimage Clin. 2016 Feb 2;11:173-80. doi: 10.1016/j.nicl.2016.01.021. eCollection 2016.

5.

Selective serotonin reuptake inhibitors for fibromyalgia syndrome.

Walitt B, Urrútia G, Nishishinya MB, Cantrell SE, Häuser W.

Cochrane Database Syst Rev. 2015 Jun 5;(6):CD011735. doi: 10.1002/14651858.CD011735. Review.

6.

Management of fibromyalgia syndrome: review of evidence.

Okifuji A, Hare BD.

Pain Ther. 2013 Dec;2(2):87-104. doi: 10.1007/s40122-013-0016-9. Epub 2013 Sep 21.

7.

Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia.

Wolfe F, Walitt BT, Katz RS, Häuser W.

PLoS One. 2014 Feb 14;9(2):e88740. doi: 10.1371/journal.pone.0088740. eCollection 2014.

8.

Acupuncture therapy: mechanism of action, efficacy, and safety: a potential intervention for psychogenic disorders?

Kawakita K, Okada K.

Biopsychosoc Med. 2014 Jan 20;8(1):4. doi: 10.1186/1751-0759-8-4.

9.

Central sensitization as a component of post-deployment syndrome.

Lewis JD, Wassermann EM, Chao W, Ramage AE, Robin DA, Clauw DJ.

NeuroRehabilitation. 2012;31(4):367-72. doi: 10.3233/NRE-2012-00805. Review.

10.

Applying the ACR Preliminary Diagnostic Criteria in the Diagnosis and Assessment of Fibromyalgia.

Kim SM, Lee SH, Kim HR.

Korean J Pain. 2012 Jul;25(3):173-82. doi: 10.3344/kjp.2012.25.3.173. Epub 2012 Jun 28.

11.

The prevalence of fibromyalgia in other chronic pain conditions.

Yunus MB.

Pain Res Treat. 2012;2012:584573. doi: 10.1155/2012/584573. Epub 2011 Nov 17.

12.

The clinical concept of fibromyalgia as a changing paradigm in the past 20 years.

Fitzcharles MA, Yunus MB.

Pain Res Treat. 2012;2012:184835. doi: 10.1155/2012/184835. Epub 2011 Oct 29.

13.

An approach to the patient with fibromyalgia.

Carette S.

Can Fam Physician. 1987 Mar;33:697-9.

14.

Fibromyalgia: Does it Exist?

Zadorozny OG.

Can Fam Physician. 1990 Sep;36:1603-6.

15.
16.

Relationship between fibromyalgia and obesity in pain, function, mood, and sleep.

Okifuji A, Donaldson GW, Barck L, Fine PG.

J Pain. 2010 Dec;11(12):1329-37. doi: 10.1016/j.jpain.2010.03.006. Epub 2010 Jun 9.

17.

Traumatic experiences, major life stressors, and self-reporting a physician-given fibromyalgia diagnosis.

Haviland MG, Morton KR, Oda K, Fraser GE.

Psychiatry Res. 2010 May 30;177(3):335-41. doi: 10.1016/j.psychres.2009.08.017. Epub 2010 Apr 10.

18.

Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials.

Arnold LM, Clauw DJ, Wohlreich MM, Wang F, Ahl J, Gaynor PJ, Chappell AS.

Prim Care Companion J Clin Psychiatry. 2009;11(5):237-44. doi: 10.4088/PCC.08m00680.

19.

Neurologic signs and symptoms in fibromyalgia.

Watson NF, Buchwald D, Goldberg J, Noonan C, Ellenbogen RG.

Arthritis Rheum. 2009 Sep;60(9):2839-44. doi: 10.1002/art.24772.

20.

Understanding fibromyalgia: lessons from the broader pain research community.

Williams DA, Clauw DJ.

J Pain. 2009 Aug;10(8):777-91. doi: 10.1016/j.jpain.2009.06.001. Review.

Supplemental Content

Support Center